Pharmacological actions of a novel O-acetylsalicylic acid composition.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology*; D001190:Arylsulfonates / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D002415:Cats; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004487:Edema / Q000188:drug therapy; D005753:Gastric Mucosa / Q000187:drug effects; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy; D008722:Methods; D051381:Rats
D000893:Anti-Inflammatory Agents; D001190:Arylsulfonates; D001241:Aspirin